Casa Sollievo della Sofferenza is a private scientific research hospital in San Giovanni Rotondo, Italy, founded by Saint Pio of Pietrelcina, and administered by Vatican City.

During the past decade, Ospedale Casa Sollievo della Sofferenza conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Casa Sollievo della Sofferenza" are "Chronic Kidney Disease" (1 trials), "Diabetic Kidney Disease" (1 trials), "Primary Sclerosing Cholangitis" (1 trials), "Refractory Diffuse Large B-Cell Lymphoma" (1 trials) and "Relapsed Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Ospedale Casa Sollievo della Sofferenza" in a lesser frequency.

Most popular intervention types in "Ospedale Casa Sollievo della Sofferenza" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clinical information" (1 trials), "Empagliflozin" (1 trials), "Finerenone (Kerendia, BAY94-8862 )" (1 trials) and "Fulacimstat (BAY1142524)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Casa Sollievo della Sofferenza" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Casa Sollievo della Sofferenza". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale Casa Sollievo della Sofferenza, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Casa Sollievo della Sofferenza, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".